The U.S. Food and Drug Administration (FDA) says it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65. That effectively limits the vaccines to older adults and those at risk of developing severe illness. Katherine Ward has this story and more in Health Matters for May 21, 2025.